Literature DB >> 25225769

Sublingual immunotherapy as an alternative to induce protection against acute respiratory infections.

Natalia Muñoz-Wolf1, Analía Rial2, José M Saavedra2, José A Chabalgoity3.   

Abstract

Sublingual route has been widely used to deliver small molecules into the bloodstream and to modulate the immune response at different sites. It has been shown to effectively induce humoral and cellular responses at systemic and mucosal sites, namely the lungs and urogenital tract. Sublingual vaccination can promote protection against infections at the lower and upper respiratory tract; it can also promote tolerance to allergens and ameliorate asthma symptoms. Modulation of lung's immune response by sublingual immunotherapy (SLIT) is safer than direct administration of formulations by intranasal route because it does not require delivery of potentially harmful molecules directly into the airways. In contrast to intranasal delivery, side effects involving brain toxicity or facial paralysis are not promoted by SLIT. The immune mechanisms underlying SLIT remain elusive and its use for the treatment of acute lung infections has not yet been explored. Thus, development of appropriate animal models of SLIT is needed to further explore its potential advantages. This work shows how to perform sublingual administration of therapeutic agents in mice to evaluate their ability to protect against acute pneumococcal pneumonia. Technical aspects of mouse handling during sublingual inoculation, precise identification of sublingual mucosa, draining lymph nodes and isolation of tissues, bronchoalveolar lavage and lungs are illustrated. Protocols for single cell suspension preparation for FACS analysis are described in detail. Other downstream applications for the analysis of the immune response are discussed. Technical aspects of the preparation of Streptococcus pneumoniae inoculum and intranasal challenge of mice are also explained. SLIT is a simple technique that allows screening of candidate molecules to modulate lungs' immune response. Parameters affecting the success of SLIT are related to molecular size, susceptibility to degradation and stability of highly concentrated formulations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25225769      PMCID: PMC4828029          DOI: 10.3791/52036

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  30 in total

1.  Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection.

Authors:  Natalia Muñoz; Laurye Van Maele; Juan M Marqués; Analía Rial; Jean-Claude Sirard; José A Chabalgoity
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Sublingual immunization induces broad-based systemic and mucosal immune responses in mice.

Authors:  Nicolas Cuburu; Mi-Na Kweon; Joo-Hye Song; Catherine Hervouet; Carmelo Luci; Jia-Bin Sun; Paul Hofman; Jan Holmgren; Fabienne Anjuère; Cecil Czerkinsky
Journal:  Vaccine       Date:  2007-10-25       Impact factor: 3.641

Review 3.  The real-time polymerase chain reaction.

Authors:  Mikael Kubista; José Manuel Andrade; Martin Bengtsson; Amin Forootan; Jiri Jonák; Kristina Lind; Radek Sindelka; Robert Sjöback; Björn Sjögreen; Linda Strömbom; Anders Ståhlberg; Neven Zoric
Journal:  Mol Aspects Med       Date:  2006-02-03

4.  Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity.

Authors:  Clément Nempont; Delphine Cayet; Martin Rumbo; Coralie Bompard; Vincent Villeret; Jean-Claude Sirard
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

5.  Carriage of antibiotic-resistant Streptococcus pneumoniae by children in eastern and central Europe--a multicenter study with use of standardized methods.

Authors:  P C Appelbaum; C Gladkova; W Hryniewicz; B Kojouharov; D Kotulova; F Mihalcu; J Schindler; L Setchanova; N Semina; J Trupl; S Tyski; P Urbaskova; M R Jacobs
Journal:  Clin Infect Dis       Date:  1996-10       Impact factor: 9.079

6.  Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.

Authors:  L Mascarell; V Lombardi; A Zimmer; A Louise; S Tourdot; L Van Overtvelt; P Moingeon
Journal:  Clin Exp Allergy       Date:  2009-08-20       Impact factor: 5.018

7.  Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered Polyvalent Mechanical Bacterial Lysates (PMBL).

Authors:  Filippo Rosaschino; Laura Cattaneo
Journal:  Acta Biomed       Date:  2004-12

8.  Neurologic adverse events following influenza A (H1N1) vaccinations in children.

Authors:  Seung Jae Lee; Young Ok Kim; Young Jong Woo; Myeong Kyu Kim; Tai-Seung Nam; Young Kuk Cho
Journal:  Pediatr Int       Date:  2012-04-09       Impact factor: 1.524

Review 9.  Mucosal immunity and sublingual immunotherapy in respiratory disorders.

Authors:  G Vitaliti; S Leonardi; M Miraglia Del Giudice; A Salpietro; L Artusio; D Caimmi; T Arrigo; C Salpietro; G Ciprandi; M La Rosa
Journal:  J Biol Regul Homeost Agents       Date:  2012 Jan-Mar       Impact factor: 1.711

Review 10.  Sublingual immunotherapy in children: an updated review.

Authors:  Chang-Hung Kuo; Wei-Li Wang; Yu-Te Chu; Min-Sheng Lee; Chih-Hsing Hung
Journal:  Pediatr Neonatol       Date:  2009-04       Impact factor: 2.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.